» Articles » PMID: 33519212

Circular RNA CircSEC24A Promotes Cutaneous Squamous Cell Carcinoma Progression by Regulating MiR-1193/MAP3K9 Axis

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2021 Feb 1
PMID 33519212
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circular RNAs (circRNAs) have been increasingly demonstrated to play critical roles in cancer progression. However, the biological functions and underlying mechanism of circRNA SEC24 homolog A, COPII coat complex component (circSEC24A) in cutaneous squamous cell carcinoma (CSCC) have not been well elucidated yet.

Methods: The expression levels of circSEC24A, microRNA-1193 (miR-1193) and mitogen-activated protein kinase kinase kinase 9 (MAP3K9) were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) or Western blot. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and colony formation assay were used to assess cell proliferation ability. Flow cytometry and transwell assay were utilized to detect cell apoptosis and migration and invasion. Glycolytic metabolism was examined via the measurement of lactate production, glucose consumption, extracellular acidification rate (ECAR), hexokinase 2 (HK2) and Lactate dehydrogenase A (LDHA) expression. The interaction between miR-1193 and circSEC24A or MAP3K9 was predicted by starBase v2.0 and verified by dual-luciferase reporter, RNA Immunoprecipitation (RIP) and pull-down assay assays. The mice xenograft model was established to investigate the roles of circSEC24A in vivo.

Results: CircSEC24A and MAP3K9 were upregulated and miR-1193 was downregulated in CSCC tissues and cells. CircSEC24A knockdown inhibited the progression of CSCC cells by inhibiting cell proliferation, migration, invasion, and glycolysis and inducing apoptosis. Moreover, miR-1193 was a direct target of circSEC24A and its downregulation reversed the inhibitory effect of circSEC24A knockdown on the progression of CSCC cells. Furthermore, MAP3K9 was a downstream target of miR-1193 and its upregulation attenuated the anti-cancer role of miR-1193 in CSCC cells. Additionally, circSEC24A acted as a molecular sponge of miR-1193 to regulate MAP3K9 expression. Furthermore, interference of circSEC24A repressed tumor growth via upregulating miR-1193 and downregulating MAP3K9.

Conclusion: CircSEC24A interference suppressed the progression of CSCC by regulating miR-1193/MAP3K9 axis, which might be a promising strategy for CSCC treatment.

Citing Articles

Integrated analysis of differential expression profile of miRNA in the uterus of seasonal estrus sheep.

Yang F, Liu J, La Y, Di R, He X, Wang P BMC Genomics. 2025; 26(1):243.

PMID: 40082757 PMC: 11905465. DOI: 10.1186/s12864-025-11401-7.


CircSEC24A induces KLF8 expression to promote the malignant progression of non-small cell lung cancer by regulating miR-1253.

Xiong W, Yang J Thorac Cancer. 2024; 15(35):2461-2473.

PMID: 39465973 PMC: 11646692. DOI: 10.1111/1759-7714.15450.


CircRNA hsa_circ_0003528/miR-215 is considered a potential target for predictive prognosis and therapy for triple-negative breast cancer.

Chang R, Yu H, Li S, Pan J Mol Biol Rep. 2024; 51(1):901.

PMID: 39126511 DOI: 10.1007/s11033-024-09808-8.


Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions.

Conley J, Genenger B, Ashford B, Ranson M Int J Mol Sci. 2024; 25(15).

PMID: 39126067 PMC: 11313315. DOI: 10.3390/ijms25158493.


CircIFFO1 suppresses tumor growth and metastasis of cutaneous squamous cell carcinoma by targeting the miR-424-5p/NFIB axis.

Yu H, Liu P, Chen T Arch Dermatol Res. 2023; 315(9):2585-2596.

PMID: 37405427 DOI: 10.1007/s00403-023-02659-6.


References
1.
Chen L, Yang L . Regulation of circRNA biogenesis. RNA Biol. 2015; 12(4):381-8. PMC: 4615371. DOI: 10.1080/15476286.2015.1020271. View

2.
Haque S, Harries L . Circular RNAs (circRNAs) in Health and Disease. Genes (Basel). 2017; 8(12). PMC: 5748671. DOI: 10.3390/genes8120353. View

3.
Samarasinghe V, Madan V, Lear J . Management of high-risk squamous cell carcinoma of the skin. Expert Rev Anticancer Ther. 2011; 11(5):763-9. DOI: 10.1586/era.11.36. View

4.
Shen L, Du X, Ma H, Mei S . miR-1193 Suppresses the Proliferation and Invasion of Human T-Cell Leukemia Cells Through Directly Targeting the Transmembrane 9 Superfamily 3 (TM9SF3). Oncol Res. 2017; 25(9):1643-1651. PMC: 7841265. DOI: 10.3727/096504017X14908284471361. View

5.
Xia J, Cao T, Ma C, Shi Y, Sun Y, Wang Z . miR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer. Mol Ther Nucleic Acids. 2018; 13:121-132. PMC: 6171162. DOI: 10.1016/j.omtn.2018.08.012. View